Vanda Pharmaceuticals (VNDA) Tops Q1 EPS by 31c
Tweet
Share
E-mail
Get Alerts VNDA Hot Sheet
Price: $6.03 +0.50%
Revenue Growth %: +17.5%
Financial Fact:
Net income (loss): -430K
Today's EPS Names:
MAYS, CRMT, REPL, More
Revenue Growth %: +17.5%
Financial Fact:
Net income (loss): -430K
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Vanda Pharmaceuticals (NASDAQ: VNDA) reported Q1 EPS of $0.14, $0.31 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $43.6 million versus the consensus estimate of $41.54 million.
For earnings history and earnings-related data on Vanda Pharmaceuticals (VNDA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
- Carnival shares drop despite earnings beat on weak guidance
- Bernstein SocGen Reiterates Outperform Rating on Fervo Energy (FRVO)
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
